Takeda is investing more in cell and gene therapy through new deals with Poseida Therapeutics and Immusoft targeting liver and neurometabolic disorders, respectively. BeiGene’s Abraxane China licensing deal with Bristol Myers Squibb’s Celgene is falling apart amid manufacturing problems and a legal battle. And more. 1. Billions club: Takeda taps Poseida for 2nd $ 1B-plus gene… Read More »
Have you ever wondered why some people who catch Covid only have a mild illness, while others become seriously ill? Well, a scientific and medical team at Newcastle University have shown that a particular gene, called HLA-DRB1*04:01, is found three times more often in people who are asymptomatic, suggesting this gene confers some level of… Read More »
“She couldn’t do the basic things. She couldn’t reach for a toy, which was five centimetres away. We couldn’t leave her alone, Even on the sofa, where she was all surrounded by cushions and pillows because everything was too dangerous,” she says. “We couldn’t relax for a second, and she couldn’t enjoy her life.” BBC… Read More »
Gyroscope Therapeutics, a retinal gene therapy company, has developed the Orbit subretinal delivery system (SDS). The technology is designed to deliver therapies to the retina without the need for invasive procedures, such as vitrectomies, which involve removing the gel-like substance within the eye, or retinotomies, which involve making a hole in the retina. The company… Read More »
By Bill Hathaway A genome-wide analysis of more than 435,000 people has identified 29 genetic variants linked to problematic drinking, researchers at Yale University School of Medicine and colleagues report May 25 in the journal Nature Neuroscience. “The new data triple the number of known genetic risk loci associated with problematic alcohol use,” said Yale’s Joel… Read More »
A genome-wide analysis of more than 435,000 people has identified 29 genetic variants linked to problematic drinking, researchers at Yale University School of Medicine and colleagues report May 25 in the journal Nature Neuroscience. “The new data triple the number of known genetic risk loci associated with problematic alcohol use,” said Yale’s Joel Gelernter, the… Read More »